These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15778355)

  • 1. Characterizing the impact of CD8 antibodies on class I MHC multimer binding.
    Holman PO; Walsh ER; Jameson SC
    J Immunol; 2005 Apr; 174(7):3986-91. PubMed ID: 15778355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.
    Wooldridge L; Hutchinson SL; Choi EM; Lissina A; Jones E; Mirza F; Dunbar PR; Price DA; Cerundolo V; Sewell AK
    J Immunol; 2003 Dec; 171(12):6650-60. PubMed ID: 14662868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
    Denkberg G; Cohen CJ; Reiter Y
    J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric class I molecules mediate TCR/CD3 epsilon/CD8 interaction on the surface of T cells.
    Block MS; Johnson AJ; Mendez-Fernandez Y; Pease LR
    J Immunol; 2001 Jul; 167(2):821-6. PubMed ID: 11441088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers.
    Daniels MA; Jameson SC
    J Exp Med; 2000 Jan; 191(2):335-46. PubMed ID: 10637277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells.
    Lee PU; Kranz DM
    Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sialyltransferase ST3Gal-I is not required for regulation of CD8-class I MHC binding during T cell development.
    Kao C; Sandau MM; Daniels MA; Jameson SC
    J Immunol; 2006 Jun; 176(12):7421-30. PubMed ID: 16751387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.
    Shore DA; Issafras H; Landais E; Teyton L; Wilson IA
    J Mol Biol; 2008 Dec; 384(5):1190-202. PubMed ID: 18929574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells.
    Schott E; Ploegh HL
    Eur J Immunol; 2002 Dec; 32(12):3425-34. PubMed ID: 12432573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor.
    Knobloch M; Schönrich G; Schenkel J; Malissen M; Malissen B; Schmitt-Verhulst AM; Hämmerling GJ; Arnold B
    Int Immunol; 1992 Oct; 4(10):1169-74. PubMed ID: 1489732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of MHC-CD8 interaction at the T cell membrane.
    Huang J; Edwards LJ; Evavold BD; Zhu C
    J Immunol; 2007 Dec; 179(11):7653-62. PubMed ID: 18025211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-capping studies reveal CD8/TCR interactions after capping CD8 beta polypeptides and intracellular associations of CD8 with p56(lck).
    Kwan Lim GE; McNeill L; Whitley K; Becker DL; Zamoyska R
    Eur J Immunol; 1998 Feb; 28(2):745-54. PubMed ID: 9521084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
    Wooldridge L; Scriba TJ; Milicic A; Laugel B; Gostick E; Price DA; Phillips RE; Sewell AK
    Eur J Immunol; 2006 Jul; 36(7):1847-55. PubMed ID: 16783852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.